clinicaloncologyКлинический случай в онкологииClinical Case in Oncology3034-14773034-4018ОНКОПРАКТИК10.62546/3034-1477-2024-2-2-49-61clinicaloncology-18Research ArticleКЛИНИЧЕСКИЕ СЛУЧАИCASE REPORTSХирургическое лечение метастазов в головной мозг: проблемы и нюансыSurgical treatment of brain metastases: problems and nuanceshttps://orcid.org/0009-0005-0550-4317КорзеневД. А.KorzenevD. A.

Корзенев Даниил Аркадьевич — врач-нейрохирург нейрохирургического отделения 

197376, Санкт-Петербург, ул. Академика Павлова, д. 12а 

Daniil A. Korzenev — neurosurgeon of the Neurosurgical Department 

St. Petersburg 

dr.korzenev@mail.ruhttps://orcid.org/0009-0007-4127-4939АлиевГ. Б.AlievG. B.

Алиев Гамзат Барилмагомедович — заведующий нейрохирургическим отделением  

197376, Санкт-Петербург, ул. Академика Павлова, д. 12а 

Gamzat B. Aliev — head of the Neurosurgical Department 

St. Petersburg 

magomedamb2@bk.ruФГБУН «Институт мозга человека им. Н. П. Бехтеревой РАН»РоссияInstitute of the Human Brain named after N. P. Bekhterev Russian Academy of SciencesRussian Federation202419062024224961Copyright © Корзенев Д.А., Алиев Г.Б., 20242024Корзенев Д.А., Алиев Г.Б.Korzenev D.A., Aliev G.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.oncocase.ru/jour/article/view/18

Метастазы в головной мозг — наиболее распространенный тип внутричерепных опухолевых образований. Современное лечение метастазов в головной мозг является сложной проблемой, и традиционно пациенты с поражением ЦНС имеют плохой прогноз. Однако успехи системной лекарственной терапии, достижения лучевых методов лечения и мультидисциплинарный, индивидуализирующий дифференциальный подход к каждому пациенту значительно увеличили показатели выживаемости в этой группе пациентов. Хирургическая резекция играет важную роль в лечении метастазов в головной мозг. В данной статье мы обсуждаем развивающуюся роль хирургического метода в лечении разнородной группы пациентов с метастатическим поражением головного мозга.

Brain metastases are the most common type of intracranial tumor formation. Modern treatment of brain metastases is a complex problem and traditionally patients with central nervous system lesions have a poor prognosis. However, advances in systemic drug therapy, advances in radiation treatments, and a multidisciplinary approach that individualizes the differential approach to each patient have significantly improved survival rates in this group of patients. Surgical resection plays an important role in the treatment of brain metastases. In this article, we discuss the evolving role of surgery in the treatment of this diverse group of patients with brain metastases.

метастазы в головной мозгхирургиярезекция единым блокомbrain metastasessurgeryen bloc resectionReferencesJemal A., Siegel R., Ward E. et al. Cancer Statistics, 2008 // CA Cancer J. Clin. 2008. Vol. 58. Р. 71–96. doi: 10.3322/CA.2007.0010.Jemal A., Siegel R., Ward E. et al. Cancer Statistics, 2008 // CA Cancer J. Clin. 2008. Vol. 58. Р. 71–96. doi: 10.3322/CA.2007.0010.Fox B.D., Cheung V.J., Patel A.J. et al. Epidemiology of Metastatic Brain Tumors // Neurosurg. Clin. N. Am. 2011. Vol. 22. Р. 1–6. doi: 10.1016/j.nec.2010.08.007.Fox B.D., Cheung V.J., Patel A.J. et al. Epidemiology of Metastatic Brain Tumors // Neurosurg. Clin. N. Am. 2011. Vol. 22. Р. 1–6. doi: 10.1016/j.nec.2010.08.007.Nayak L., Lee E.Q., Wen P.Y. Epidemiology of Brain Metastases // Curr. Oncol. Rep. 2012. Vol. 14. Р. 48–54. doi: 10.1007/s11912-011-0203-y.Nayak L., Lee E.Q., Wen P.Y. Epidemiology of Brain Metastases // Curr. Oncol. Rep. 2012. Vol. 14. Р. 48–54. doi: 10.1007/s11912-011-0203-y.Brastianos P.K., Curry W.T., Oh K.S. Clinical Discussion and Review of the Management of Brain Metastases // J. Natl. Compr. Canc. Netw. 2013. Vol. 11. Р. 1153–1164. doi: 10.6004/jnccn.2013.0133.Brastianos P.K., Curry W.T., Oh K.S. Clinical Discussion and Review of the Management of Brain Metastases // J. Natl. Compr. Canc. Netw. 2013. Vol. 11. Р. 1153–1164. doi: 10.6004/jnccn.2013.0133.Eichler A.F., Chung E., Kodack D.P. et al. The Biology of Brain Metastases-Translation to New Therapies // Nat. Rev. Clin. Oncol. 2011. Vol. 8. Р. 344–356. doi: 10.1038/nrclinonc.2011.58.Eichler A.F., Chung E., Kodack D.P. et al. The Biology of Brain Metastases-Translation to New Therapies // Nat. Rev. Clin. Oncol. 2011. Vol. 8. Р. 344–356. doi: 10.1038/nrclinonc.2011.58.Delattre J.Y., Krol G., Thaler H.T., et al. Distribution of Brain Metastases // Arch. Neurol. 1988. Vol. 45. Р. 741–744. doi: 10.1001/archneur.1988.00520310047016Delattre J.Y., Krol G., Thaler H.T., et al. Distribution of Brain Metastases // Arch. Neurol. 1988. Vol. 45. Р. 741–744. doi: 10.1001/archneur.1988.00520310047016Gavrilovic I.T., Posner J.B. Brain Metastases: Epidemiology and Pathophysiology // J. Neurooncol. 2005. Vol. 75. Р. 5–14. doi: 10.1007/s11060-004-8093-6.Gavrilovic I.T., Posner J.B. Brain Metastases: Epidemiology and Pathophysiology // J. Neurooncol. 2005. Vol. 75. Р. 5–14. doi: 10.1007/s11060-004-8093-6.Kibbi N., Kluger H. The Treatment of Melanoma Brain Metastases // Curr. Oncol. Rep. 2016. Vol. 18. Р. 73. doi: 10.1007/s11912-016-0555-4.Kibbi N., Kluger H. The Treatment of Melanoma Brain Metastases // Curr. Oncol. Rep. 2016. Vol. 18. Р. 73. doi: 10.1007/s11912-016-0555-4.Rostami R., Mittal S., Rostami P. et al. Brain Metastasis in Breast Cancer: A Comprehensive Literature Review // J. Neurooncol. 2016. Vol. 127. Р. 407–414. doi: 10.1007/s11060-016-2075-3.Rostami R., Mittal S., Rostami P. et al. Brain Metastasis in Breast Cancer: A Comprehensive Literature Review // J. Neurooncol. 2016. Vol. 127. Р. 407–414. doi: 10.1007/s11060-016-2075-3.Guérin A., Sasane M., Dea K. et al. The Economic Burden of Brain Metastasis Among Lung Cancer Patients in the United States // J. Med. Econ. 2016. Vol. 19, No. 5. Р. 526–536. doi: 10.3111/13696998.2016.1138962.Guérin A., Sasane M., Dea K. et al. The Economic Burden of Brain Metastasis Among Lung Cancer Patients in the United States // J. Med. Econ. 2016. Vol. 19, No. 5. Р. 526–536. doi: 10.3111/13696998.2016.1138962.Patchell R.A., Tibbs P.A., Walsh J.W. et al. A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain // N. Engl. J. Med. 1990. Vol. 322. Р. 494–500. doi: 10.1056/NEJM199002223220802.Patchell R.A., Tibbs P.A., Walsh J.W. et al. A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain // N. Engl. J. Med. 1990. Vol. 322. Р. 494–500. doi: 10.1056/NEJM199002223220802.Vecht C.J., Haaxma-Reiche H., Noordijk E.M. et al. Treatment of Single Brain Metastasis: Radiotherapy Alone or Combined With Neurosurgery? // Ann. Neurol. 1993. Vol. 33. Р. 583–590. doi: 10.1002/ana.410330605.Vecht C.J., Haaxma-Reiche H., Noordijk E.M. et al. Treatment of Single Brain Metastasis: Radiotherapy Alone or Combined With Neurosurgery? // Ann. Neurol. 1993. Vol. 33. Р. 583–590. doi: 10.1002/ana.410330605.Chang E.L., Wefel J.S., Hess K.R. et al. Neurocognition in Patients With Brain Metastases Treated With Radiosurgery or Radiosurgery Plus Whole-Brain Irradiation: A Randomised Controlled Trial // Lancet Oncol. 2009. Vol. 10, No. 11. Р. 1037–1044. doi: 10.1016/S1470-2045(09)70263-3.Chang E.L., Wefel J.S., Hess K.R. et al. Neurocognition in Patients With Brain Metastases Treated With Radiosurgery or Radiosurgery Plus Whole-Brain Irradiation: A Randomised Controlled Trial // Lancet Oncol. 2009. Vol. 10, No. 11. Р. 1037–1044. doi: 10.1016/S1470-2045(09)70263-3.Aoyama H., Tago M., Kato N. et al. Neurocognitive Function of Patients With Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68. Р. 1388–1395. doi: 10.1016/j.ijrobp.2007.03.048.Aoyama H., Tago M., Kato N. et al. Neurocognitive Function of Patients With Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68. Р. 1388–1395. doi: 10.1016/j.ijrobp.2007.03.048.Tallet A.V., Azria D., Barlesi F. et al. Neurocognitive Function Impairment After Whole Brain Radiotherapy for Brain Metastases: Actual Assessment // Radiat. Oncol. 2012. Vol. 7. Р. 77. doi: 10.1186/1748-717X-7-77.Tallet A.V., Azria D., Barlesi F. et al. Neurocognitive Function Impairment After Whole Brain Radiotherapy for Brain Metastases: Actual Assessment // Radiat. Oncol. 2012. Vol. 7. Р. 77. doi: 10.1186/1748-717X-7-77.Prabhu R.S., Press R.H., Patel K.R. et al. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-Institutional Analysis // Int. J. Radiat. Oncol. Biol. Phys. 2017. Vol. 99. Р. 459–467. doi: 10.1016/j.ijrobp.2017.04.006.Prabhu R.S., Press R.H., Patel K.R. et al. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-Institutional Analysis // Int. J. Radiat. Oncol. Biol. Phys. 2017. Vol. 99. Р. 459–467. doi: 10.1016/j.ijrobp.2017.04.006.Gupta S., Dawood H., Giantini Larsen A. et al. Surgical and Peri-Operative Considerations for Brain Metastases // Front Oncol. 2021. Vol. 5. Р. 662943. doi: 10.3389/fonc.2021.662943.Gupta S., Dawood H., Giantini Larsen A. et al. Surgical and Peri-Operative Considerations for Brain Metastases // Front Oncol. 2021. Vol. 5. Р. 662943. doi: 10.3389/fonc.2021.662943.Tendulkar R.D., Liu S.W., Barnett G.H. et al. RPA Classification has Prognostic Significance for Surgically Resected Single Brain Metastasis // Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 66. Р. 810–817. doi: 10.1016/j.ijrobp.2006.06.003.Tendulkar R.D., Liu S.W., Barnett G.H. et al. RPA Classification has Prognostic Significance for Surgically Resected Single Brain Metastasis // Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 66. Р. 810–817. doi: 10.1016/j.ijrobp.2006.06.003.Sperduto P.W., Chao S.T., Sneed P.K. et al. Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77. Р. 655–661. doi: 10.1016/j.ijrobp.2009.08.025.Sperduto P.W., Chao S.T., Sneed P.K. et al. Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77. Р. 655–661. doi: 10.1016/j.ijrobp.2009.08.025.Sperduto C.M., Watanabe Y., Mullan J. et al. A Validation Study of a New Prognostic Index for Patients With Brain Metastases: The Graded Prognostic Assessment // J. Neurosurg. 2008. Vol. 109, Suppl. Р. 87–89. doi: 10.3171/JNS/2008/109/12/S14.Sperduto C.M., Watanabe Y., Mullan J. et al. A Validation Study of a New Prognostic Index for Patients With Brain Metastases: The Graded Prognostic Assessment // J. Neurosurg. 2008. Vol. 109, Suppl. Р. 87–89. doi: 10.3171/JNS/2008/109/12/S14.Sperduto P.W., Berkey B., Gaspar L.E. et al. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1, 960 Patients in the RTOG Database // Int. J. Radiat. Oncol.Biol. Phys. 2008. Vol. 70. Р. 510–514. doi: 10.1016/j.ijrobp.2007.06.074.Sperduto P.W., Berkey B., Gaspar L.E. et al. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1, 960 Patients in the RTOG Database // Int. J. Radiat. Oncol.Biol. Phys. 2008. Vol. 70. Р. 510–514. doi: 10.1016/j.ijrobp.2007.06.074.Lee C.H., Kim D.G. et al. The Role of Surgical Resection in the Management of Brain Metastasis: A 17-Year Longitudinal Study // Acta Neurochir. (Wien). 2013. Vol. 155. Р. 389–397. doi: 10.1007/s00701–013–1619-y.Lee C.H., Kim D.G. et al. The Role of Surgical Resection in the Management of Brain Metastasis: A 17-Year Longitudinal Study // Acta Neurochir. (Wien). 2013. Vol. 155. Р. 389–397. doi: 10.1007/s00701–013–1619-y.Patel A.J., Suki D., Hatiboglu M.A. et al. Factors Influencing the Risk of Local Recurrence After Resection of a Single Brain Metastasis // J. Neurosurg. 2010. Vol. 113, No. 2. Р. 181–189. doi: 10.3171/2009.11.JNS09659.Patel A.J., Suki D., Hatiboglu M.A. et al. Factors Influencing the Risk of Local Recurrence After Resection of a Single Brain Metastasis // J. Neurosurg. 2010. Vol. 113, No. 2. Р. 181–189. doi: 10.3171/2009.11.JNS09659.Patel A.J., Suki D., Hatiboglu M.A. et al. Impact of Surgical Methodology on the Complication Rate and Functional Outcome of Patients With a Single Brain Metastasis // J. Neurosurg. 2015. Vol. 122. Р. 1132–1143. doi: 10.3171/2014.9.JNS13939.Patel A.J., Suki D., Hatiboglu M.A. et al. Impact of Surgical Methodology on the Complication Rate and Functional Outcome of Patients With a Single Brain Metastasis // J. Neurosurg. 2015. Vol. 122. Р. 1132–1143. doi: 10.3171/2014.9.JNS13939.Groves M.D. Leptomeningeal Disease // Neurosurg. Clin. N. Am. 2011. Vol. 22, No. 1. Р. 67–78, vii. doi: 10.1016/j.nec.2010.08.006.Groves M.D. Leptomeningeal Disease // Neurosurg. Clin. N. Am. 2011. Vol. 22, No. 1. Р. 67–78, vii. doi: 10.1016/j.nec.2010.08.006.Le Rhun E., Taillibert S., Chamberlain M.C. Carcinomatous Meningitis: Leptomeningeal Metastases in Solid Tumors // Surg. Neurol.Int. 2013. Vol. 4, Suppl. 4. S265–288. doi: 10.4103/2152–7806.111304Le Rhun E., Taillibert S., Chamberlain M.C. Carcinomatous Meningitis: Leptomeningeal Metastases in Solid Tumors // Surg. Neurol.Int. 2013. Vol. 4, Suppl. 4. S265–288. doi: 10.4103/2152–7806.111304Suki D., Abouassi H., Patel A.J. et al. Comparative Risk of Leptomeningeal Disease After Resection or Stereotactic Radiosurgery for Solid Tumor Metastasis to the Posterior Fossa // J. Neurosurg. 2008. Vol. 108, No. 2 Р. 248–257. doi: 10.3171/JNS/2008/108/2/0248.Suki D., Abouassi H., Patel A.J. et al. Comparative Risk of Leptomeningeal Disease After Resection or Stereotactic Radiosurgery for Solid Tumor Metastasis to the Posterior Fossa // J. Neurosurg. 2008. Vol. 108, No. 2 Р. 248–257. doi: 10.3171/JNS/2008/108/2/0248.Suki D., Hatiboglu M.A., Patel A.J. et al. Comparative Risk of Leptomeningeal Dissemination of Cancer After Surgery or Stereotactic Radiosurgery for a Single Supratentorial Solid Tumor Metastasis // Neurosurgery. 2009. Vol. 64, Nо. 4. Р. 664–674; discussion 674–6. doi: 10.1227/01.NEU.0000341535.53720.3E.Suki D., Hatiboglu M.A., Patel A.J. et al. Comparative Risk of Leptomeningeal Dissemination of Cancer After Surgery or Stereotactic Radiosurgery for a Single Supratentorial Solid Tumor Metastasis // Neurosurgery. 2009. Vol. 64, Nо. 4. Р. 664–674; discussion 674–6. doi: 10.1227/01.NEU.0000341535.53720.3E.Schödel P., Jünger S.T., Wittersheim M. et al. Surgical Resection of Symptomatic Brain Metastases Improves the Clinical Status and Facilitates Further Treatment // Cancer Med. 2020. Vol. 9, No. 20. Р. 7503–7510. doi: 10.1002/cam4.3402.Schödel P., Jünger S.T., Wittersheim M. et al. Surgical Resection of Symptomatic Brain Metastases Improves the Clinical Status and Facilitates Further Treatment // Cancer Med. 2020. Vol. 9, No. 20. Р. 7503–7510. doi: 10.1002/cam4.3402.Bindal R.K., Sawaya R., Leavens M.E. Surgical Treatment of Multiple Brain Metastases // J. Neurosurg. 1993. Vol. 79. Р. 210–216. doi: 10.3171/jns.1993.79.2.0210.Bindal R.K., Sawaya R., Leavens M.E. Surgical Treatment of Multiple Brain Metastases // J. Neurosurg. 1993. Vol. 79. Р. 210–216. doi: 10.3171/jns.1993.79.2.0210.Salvati M., Tropeano M.P., Maiola V. et al. Multiple Brain Metastases: A Surgical Series and Neurosurgical Perspective // Neurol. Sci. 2018. Vol. 39, No. 4. Р. 671–677. doi: 10.1007/s10072-017-3220-2.Salvati M., Tropeano M.P., Maiola V. et al. Multiple Brain Metastases: A Surgical Series and Neurosurgical Perspective // Neurol. Sci. 2018. Vol. 39, No. 4. Р. 671–677. doi: 10.1007/s10072-017-3220-2.Schackert G., Lindner C., Petschke S. et al. Retrospective Study of 127 Surgically Treated Patients With Multiple Brain Metastases: Indication., Prognostic Factors., and Outcome // Acta Neurochir (Wien). 2013. Vol. 3, No. 155. P. 379–387. doi: 10.1007/s00701-012-1606-8.Schackert G., Lindner C., Petschke S. et al. Retrospective Study of 127 Surgically Treated Patients With Multiple Brain Metastases: Indication., Prognostic Factors., and Outcome // Acta Neurochir (Wien). 2013. Vol. 3, No. 155. P. 379–387. doi: 10.1007/s00701-012-1606-8.Schackert G., Schmiedel K., Lindner C. et al. Surgery of Recurrent Brain Metastases: Retrospective Analysis of 67 Patients // Acta Neurochir (Wien). 2013. Vol. 155. Р. 1823–1832. doi: 10.1007/s00701-013-1821-y.Schackert G., Schmiedel K., Lindner C. et al. Surgery of Recurrent Brain Metastases: Retrospective Analysis of 67 Patients // Acta Neurochir (Wien). 2013. Vol. 155. Р. 1823–1832. doi: 10.1007/s00701-013-1821-y.Minniti G., Clarke E., Lanzetta G. et al. Stereotactic Radiosurgery for Brain Metastases: Analysis of Outcome and Risk of Brain Radionecrosis // Radiat. Oncol. 2011. Vol. 6. Р. 48. doi: 10.1186/1748-717X-6-48.Minniti G., Clarke E., Lanzetta G. et al. Stereotactic Radiosurgery for Brain Metastases: Analysis of Outcome and Risk of Brain Radionecrosis // Radiat. Oncol. 2011. Vol. 6. Р. 48. doi: 10.1186/1748-717X-6-48.Minniti G., D’Angelillo R.M., Scaringi C. et al. Fractionated Stereotactic Radiosurgery for Patients With Brain Metastases // J. Neurooncol. 2014. Vol. 117. Р. 295–301. doi: 10.1007/s11060-014-1388-3.Minniti G., D’Angelillo R.M., Scaringi C. et al. Fractionated Stereotactic Radiosurgery for Patients With Brain Metastases // J. Neurooncol. 2014. Vol. 117. Р. 295–301. doi: 10.1007/s11060-014-1388-3.Telera S., Fabi A., Pace A. et al. Radionecrosis Induced by Stereotactic Radiosurgery of Brain Metastases: Results of Surgery and Outcome of Disease // J. Neurooncol. Vol. 113. Р. 313–325. doi: 10.1007/s11060-013-1120-8.Telera S., Fabi A., Pace A. et al. Radionecrosis Induced by Stereotactic Radiosurgery of Brain Metastases: Results of Surgery and Outcome of Disease // J. Neurooncol. Vol. 113. Р. 313–325. doi: 10.1007/s11060-013-1120-8.Hughes R.T., Masters A.H., McTyre E.R. et al. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience // Int. J. Radiat. Oncol. Biol. Phys. 2019. Vol. 104, No. 5. Р. 1091–1098. doi: 10.1016/j.ijrobp.2019.03.052.Hughes R.T., Masters A.H., McTyre E.R. et al. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience // Int. J. Radiat. Oncol. Biol. Phys. 2019. Vol. 104, No. 5. Р. 1091–1098. doi: 10.1016/j.ijrobp.2019.03.052.Lee D., Riestenberg R.A., Haskell-Mendoza A. Brain Metastasis Recurrence Versus Radiation Necrosis: Evaluation and Treatment // Neurosurg. Clin. N. Am. 2020. Vol. 31, No. 4. Р. 575–587. doi: 10.1016/j.nec.2020.06.007.Lee D., Riestenberg R.A., Haskell-Mendoza A. Brain Metastasis Recurrence Versus Radiation Necrosis: Evaluation and Treatment // Neurosurg. Clin. N. Am. 2020. Vol. 31, No. 4. Р. 575–587. doi: 10.1016/j.nec.2020.06.007.Miyatake S., Nonoguchi N., Furuse M. et al. Pathophysiology, Diagnosis, and Treatment of Radiation Necrosis in the Brain // Neurol. Med. Chir. (Tokyo). 2015. Vol. 55, No. 1. Р. 50–59. doi: 10.2176/nmc.ra.2014-0188.Miyatake S., Nonoguchi N., Furuse M. et al. Pathophysiology, Diagnosis, and Treatment of Radiation Necrosis in the Brain // Neurol. Med. Chir. (Tokyo). 2015. Vol. 55, No. 1. Р. 50–59. doi: 10.2176/nmc.ra.2014-0188.Rabinov J.D., Lee P.L., Barker F.G. et al. In Vivo 3-T MR Spectroscopy in the Distinction of Recurrent Glioma Versus Radiation Effects: Initial Experience // Radiology. 2002. Vol. 225. Р. 871–879. doi: 10.1148/radiol.2253010997.Rabinov J.D., Lee P.L., Barker F.G. et al. In Vivo 3-T MR Spectroscopy in the Distinction of Recurrent Glioma Versus Radiation Effects: Initial Experience // Radiology. 2002. Vol. 225. Р. 871–879. doi: 10.1148/radiol.2253010997.Schlemmer H.P., Bachert P., Henze M. et al. Differentiation of Radiation Necrosis From Tumor Progression Using Proton Magnetic Resonance Spectroscopy // Neuroradiology. 2002. Vol. 44. Р. 216–222. doi: 10.1007/s002340100703.Schlemmer H.P., Bachert P., Henze M. et al. Differentiation of Radiation Necrosis From Tumor Progression Using Proton Magnetic Resonance Spectroscopy // Neuroradiology. 2002. Vol. 44. Р. 216–222. doi: 10.1007/s002340100703.Rock J.P., Scarpace L., Hearshen D. et al. Associations Among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology With Special Attention to Radiation Necrosis // Neurosurgery. 2004. Vol. 54. Р. 1111–1117; discussion 1117–1119. doi: 10.1227/01.neu.0000119328.56431.a7.Rock J.P., Scarpace L., Hearshen D. et al. Associations Among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology With Special Attention to Radiation Necrosis // Neurosurgery. 2004. Vol. 54. Р. 1111–1117; discussion 1117–1119. doi: 10.1227/01.neu.0000119328.56431.a7.Sugahara T., Korogi Y., Tomiguchi S. et al. Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-Sensitive Contrast-Enhanced MR Imaging for Differentiating Tumor Recurrence From Nonneoplastic Contrast-Enhancing Tissue // AJNR Am. J. Neuroradiol. 2000. Vol. 21. Р. 901–909.Sugahara T., Korogi Y., Tomiguchi S. et al. Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-Sensitive Contrast-Enhanced MR Imaging for Differentiating Tumor Recurrence From Nonneoplastic Contrast-Enhancing Tissue // AJNR Am. J. Neuroradiol. 2000. Vol. 21. Р. 901–909.Di Chiro G., Oldfield E., Wright D.C. et al. Cerebral Necrosis After Radiotherapy and/or Intraarterial Chemotherapy for Brain Tumors: PET and Neuropathologic Studies // AJR Am. J. Roentgenol. 1988. Vol. 150. Р. 189–197. doi: 10.2214/ajr.150.1.189.Di Chiro G., Oldfield E., Wright D.C. et al. Cerebral Necrosis After Radiotherapy and/or Intraarterial Chemotherapy for Brain Tumors: PET and Neuropathologic Studies // AJR Am. J. Roentgenol. 1988. Vol. 150. Р. 189–197. doi: 10.2214/ajr.150.1.189.Doyle W.K., Budinger T.F., Valk P.E. et al. Differentiation of Cerebral Radiation Necrosis From Tumor Recurrence by [18F]FDG and 82Rb Positron Emission Tomography // J. Comput. Assist. Tomogr. 1987. Vol. 11. Р. 563–570. doi: 10.1097/00004728-198707000-00001.Doyle W.K., Budinger T.F., Valk P.E. et al. Differentiation of Cerebral Radiation Necrosis From Tumor Recurrence by [18F]FDG and 82Rb Positron Emission Tomography // J. Comput. Assist. Tomogr. 1987. Vol. 11. Р. 563–570. doi: 10.1097/00004728-198707000-00001.Glantz M.J., Hoffman J.M., Coleman R.E. et al. Identification of Early Recurrence of Primary Central Nervous System Tumors by [18F] Fluorodeoxyglucose Positron Emission Tomography // Ann. Neurol. 1991. Vol. 29. Р. 347– 355. doi: 10.1002/ana.410290403.Glantz M.J., Hoffman J.M., Coleman R.E. et al. Identification of Early Recurrence of Primary Central Nervous System Tumors by [18F] Fluorodeoxyglucose Positron Emission Tomography // Ann. Neurol. 1991. Vol. 29. Р. 347– 355. doi: 10.1002/ana.410290403.Boothe D., Young R., Yamada Y. et al. Bevacizumab as a Treatment for Radiation Necrosis of Brain Metastases Post Stereotactic Radio-Surgery // Neurooncology. 2013. Vol. 15. Р. 1257–1263. doi: 10.1093/neuonc/not085.Boothe D., Young R., Yamada Y. et al. Bevacizumab as a Treatment for Radiation Necrosis of Brain Metastases Post Stereotactic Radio-Surgery // Neurooncology. 2013. Vol. 15. Р. 1257–1263. doi: 10.1093/neuonc/not085.Levin V.A., Bidaut L., Hou P. et al. Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 79. Р. 1487–1495. doi: 10.1016/j.ijrobp.2009.12.061.Levin V.A., Bidaut L., Hou P. et al. Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 79. Р. 1487–1495. doi: 10.1016/j.ijrobp.2009.12.061.Kano H., Kondziolka D., Zorro O. et al. The Results of Resection After Stereotactic Radiosurgery for Brain Metastases // J. Neurosurg. 2009. Vol. 111, No. 4. Р. 825–831. doi: 10.3171/2009.4.JNS09246.Kano H., Kondziolka D., Zorro O. et al. The Results of Resection After Stereotactic Radiosurgery for Brain Metastases // J. Neurosurg. 2009. Vol. 111, No. 4. Р. 825–831. doi: 10.3171/2009.4.JNS09246.Mitsuya K., Nakasu Y., Hayashi N. et al. Retrospective Analysis of Salvage Surgery for Local Progression of Brain Metastasis Previously Treated With Stereotactic Irradiation: Diagnostic Contribution, Functional Outcome, and Prognostic Factors // BMC Cancer. 2020. Vol. 20, No. 1. Р. 331. doi: 10.1186/s12885-020-06800-w.Mitsuya K., Nakasu Y., Hayashi N. et al. Retrospective Analysis of Salvage Surgery for Local Progression of Brain Metastasis Previously Treated With Stereotactic Irradiation: Diagnostic Contribution, Functional Outcome, and Prognostic Factors // BMC Cancer. 2020. Vol. 20, No. 1. Р. 331. doi: 10.1186/s12885-020-06800-w.

The authors declare that there are no conflicts of interest present.